Literature DB >> 21857820

Current concepts in the pathophysiology and management of hepatic encephalopathy.

R Todd Frederick1.   

Abstract

Hepatic encephalopathy (HE) represents a broad continuum of neuropsychological dysfunction in patients with acute or chronic liver disease and/or portosystemic shunting of blood flow. The pathophysiology of this disease is quite complex, as it involves overproduction and reduced metabolism of various neurotoxins, particularly ammonia. Recent hypotheses implicate low-grade cerebral edema as a final common pathway for the pathophysiology of HE. Management of this condition is multifaceted and requires several steps: elimination of precipitating factors; removal of toxins, both by reducing them at their source and by augmenting scavenging pathways; modulation of resident fecal flora; proper nutritional support; and downregulation of systemic and gut-derived inflammation.

Entities:  

Keywords:  Hepatic encephalopathy; ammonia; cerebral edema; glutaminase; urea cycle

Year:  2011        PMID: 21857820      PMCID: PMC3127024     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  101 in total

1.  Management of hepatocerebral intoxication.

Authors:  R T MANNING; M DELP
Journal:  N Engl J Med       Date:  1958-01-09       Impact factor: 91.245

2.  Synergism between ammonia and fatty acids in the production of coma: implications for hepatic coma.

Authors:  F J Zieve; L Zieve; W M Doizaki; R B Gilsdorf
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

3.  Renal ammoniagenesis during the adaptation to metabolic acidosis in man.

Authors:  A Tizianello; G Deferrari; G Garibotto; C Robaudo; M Bruzzone; G C Passerone
Journal:  Contrib Nephrol       Date:  1982       Impact factor: 1.580

4.  Ammonia production in germ-free Eck fistula dogs.

Authors:  F C Nance; R C Batson; D G Kline
Journal:  Surgery       Date:  1971-08       Impact factor: 3.982

5.  Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy.

Authors:  M Olasmaa; J D Rothstein; A Guidotti; R J Weber; S M Paul; S Spector; M L Zeneroli; M Baraldi; E Costa
Journal:  J Neurochem       Date:  1990-12       Impact factor: 5.372

6.  Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

Authors:  C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

7.  A randomized controlled trial of acarbose in hepatic encephalopathy.

Authors:  Sandro Gentile; Giuseppina Guarino; Marco Romano; Ivo A Alagia; Maura Fierro; Stefano Annunziata; Paolo L Magliano; Antonietta G Gravina; Roberto Torella
Journal:  Clin Gastroenterol Hepatol       Date:  2005-02       Impact factor: 11.382

Review 8.  Benzodiazepine receptor antagonists for hepatic encephalopathy.

Authors:  B Als-Nielsen; L L Gluud; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2004

9.  The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis.

Authors:  E Strauss; M F da Costa
Journal:  Hepatogastroenterology       Date:  1998 May-Jun

10.  Neomycin reduces the intestinal production of ammonia from glutamine.

Authors:  R A Hawkins; J Jessy; A M Mans; A Chedid; M R DeJoseph
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

View more
  9 in total

1.  A SPECIAL MEETING REVIEW EDITIONAdvances in Hepatic Encephalopathy From EASL 2014: A Review of Selected Presentations From the 49th Annual Meeting of the European Association for the Study of the LiverApril 9-13, 2014 • London, United KingdomWith Expert Commentary by: Steven L. Flamm, MDProfessor of Medicine and SurgeryDivision of Gastroenterology and HepatologyChief of the Liver Transplantation ProgranNorthwestern University Feinberg School of MedicineChicago, Illinois.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-07

2.  Amelioration of thioacetamide-induced hepatic encephalopathy in rats by low-dose gamma irradiation.

Authors:  Mona Abd El-Latif El-Ghazaly; Engy Refaat Rashed; Ghada Mahmoud Shafey; Hala Fahmy Zaki; Amina Salem Attia
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-30       Impact factor: 4.223

Review 3.  The Current Hepatic Encephalopathy Pipeline.

Authors:  Alexander J Ryu; Robert S Rahimi; Michael D Leise
Journal:  J Clin Exp Hepatol       Date:  2020-01-14

4.  Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes.

Authors:  M Farjam; P Dehdab; F Abbassnia; D Mehrabani; N Tanideh; S Pakbaz; M H Imanieh
Journal:  Iran Red Crescent Med J       Date:  2012-03-01       Impact factor: 0.611

5.  Acetyl-L-carnitine for patients with hepatic encephalopathy.

Authors:  Arturo J Martí-Carvajal; Christian Gluud; Ingrid Arevalo-Rodriguez; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2019-01-05

6.  The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients.

Authors:  Jofre Tenorio-Laranga; Carmina Montoliu; Amparo Urios; Vicente Hernandez-Rabaza; Hanan Ahabrach; J Arturo García-Horsman; Vicente Felipo
Journal:  J Neuroinflammation       Date:  2015-09-30       Impact factor: 8.322

7.  Effects of NH4CL application and removal on astrocytes and endothelial cells.

Authors:  Miha Bartolić; Andrej Vovk; Dušan Šuput
Journal:  Cell Mol Biol Lett       Date:  2016-08-23       Impact factor: 5.787

8.  Comparative Effectiveness and Safety of Polyethylene Glycol Electrolyte Solution Versus Lactulose for Treatment of Hepatic Encephalopathy: A Systematic Review and Meta-analysis.

Authors:  Mengting Li; Zhijie Zhang; Qiao Chen; Xiaoling Zhou; Diankui Shui; Jiean Huang
Journal:  J Clin Gastroenterol       Date:  2022-01-01       Impact factor: 3.062

9.  Hyponatremia: A Risk Factor for Early Overt Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.

Authors:  Jonathan Merola; Noami Chaudhary; Meng Qian; Alexander Jow; Katherine Barboza; Hearns Charles; Lewis Teperman; Samuel Sigal
Journal:  J Clin Med       Date:  2014-04-04       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.